STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,973,661 | +27.6% | 185,669 | 0.0% | 0.28% | +23.3% |
Q1 2023 | $1,546,623 | -78.1% | 185,669 | -75.7% | 0.22% | -79.7% |
Q4 2022 | $7,046,699 | -28.1% | 763,456 | 0.0% | 1.10% | -35.2% |
Q3 2022 | $9,803,000 | -2.8% | 763,456 | 0.0% | 1.69% | -37.1% |
Q2 2022 | $10,085,000 | -41.1% | 763,456 | -6.1% | 2.69% | -27.3% |
Q1 2022 | $17,123,000 | -8.9% | 813,456 | +3.8% | 3.70% | +1.2% |
Q4 2021 | $18,803,000 | +149.0% | 783,769 | +164.1% | 3.66% | +96.8% |
Q3 2021 | $7,551,000 | -24.4% | 296,822 | 0.0% | 1.86% | -10.1% |
Q2 2021 | $9,991,000 | – | 296,822 | – | 2.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 296,822 | $9,991,000 | 2.07% |
RTW INVESTMENTS, LP | 3,644,248 | $122,665,000 | 1.85% |
Cormorant Asset Management, LP | 1,278,276 | $43,027,000 | 1.46% |
Redmile Group, LLC | 2,458,558 | $82,755,000 | 1.22% |
SPHERA FUNDS MANAGEMENT LTD. | 233,135 | $7,847,000 | 0.53% |
Birchview Capital, LP | 15,000 | $505,000 | 0.30% |
Perceptive Advisors | 1,343,956 | $45,238,000 | 0.29% |
GILDER GAGNON HOWE & CO LLC | 1,245,956 | $41,939,000 | 0.21% |
Artal Group S.A. | 250,000 | $8,415,000 | 0.17% |
Casdin Capital, LLC | 120,000 | $4,039,000 | 0.10% |